Umeclidinium Bromide 62.5 mcg Suppliers & Bulk Manufacturers
Available Forms: dry-powder inhaler
Available Strengths: 62.5 mcg
Reference Brands: Incruse Ellipta (USA)
Category: Respiratory Disorder
Umeclidinium bromide is a long-acting muscarinic antagonist (LAMA) used for the maintenance treatment of COPD. By blocking muscarinic receptors (especially M3) in airway smooth muscle, it causes bronchodilation and helps improve airflow. It is given once daily via a dry-powder inhaler, making it convenient for long-term therapy. Clinical trials have shown that it provides sustained lung function improvement and is generally well tolerated, with a low risk of systemic anticholinergic side effects.
Umeclidinium Bromide — third party manufacturing & bulk supply
Umeclidinium Bromide 62.5 mcg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Umeclidinium Bromide listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Umeclidinium Bromide →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Umeclidinium Bromide is used for the long-term maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It helps improve airflow and reduce breathing difficulties.
Umeclidinium Bromide contains the active ingredient umeclidinium bromide, a long-acting muscarinic antagonist (LAMA), along with standard inhalation excipients depending on the formulation.
The widely known trade name is Incruse Ellipta.
It is manufactured by GlaxoSmithKline (GSK) and also produced by other authorized manufacturers in regulated markets.
The generic name is umeclidinium bromide.
The brand name is Incruse Ellipta.
It is manufactured in various regulated pharmaceutical facilities worldwide, including production sites operated by GlaxoSmithKline and other approved global manufacturers.
Related Products
Salmeterol Xinafoate
Strength:
25 µg, 50 µg
Form: Inhalation
Reference Brands: Serevent (USA/LATAM/EU)
View Details
Formoterol Fumarate
Strength:
12 µg
Form: Inhalation
Reference Brands: Foradil (USA/LATAM), Oxis (India)
View Details
Ethionamide
Strength:
250 mg
Form: Tablets
Reference Brands: Generic formulations marketed under different names
View Details
Olodaterol
Strength:
2.5 mcg
Form: Inhalation solution
Reference Brands: Striverdi Respimat (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
